Donations

The Department of Internal Medicine III aims to provide a patient-friendly service and the highest quality of medical care. In addition, the clinic's scientific staff endeavour to conduct basic, translational and clinical research at the highest level. In order to maintain and further expand our leading position in patient care and research on a national and international level, we are increasingly dependent on private donations in addition to income from patient care, the university's research and teaching budget and third-party funding from public organisations and non-public foundations. We would like to thank all patients and relatives who have supported us so generously in the past. Every donation helps us.

Donation account:

Ulm University Hospital
DE16 63050000 0000 1064 78
Swift-BIC: solades1ulm
Sparkasse Ulm, 89073 Ulm, Germany

Intended use


Donation account: "Leukaemia and cancer research"
Project no. D.3000

Donation account: "Palliative medicine"
Project no. D.3001

Donation account: "Rheumatism and infection research"
Project no. D.3002

Donation account: "Blood stem cell and bone marrow transplantation"
Project no. D.4800

Donation account: "VIV-ARTE® training concept"
Project no. D.6016

Donation account: "Infection research"
Project no. D.7300

Donation account: "Echinococcosis Research Infection"
Project no. D.7038

Projects

One of the most important projects in the coming years for which we are seeking donations is the decoding of genetic changes in tumour diseases with the help of new DNA sequencing technologies ("next-generation sequencing"). The rapid progress in the development of these technologies will be an important step towards "personalised medicine", i.e. being able to offer patients a therapy tailored to their individual tumour disease.
Another major focus is the further development of cellular immunotherapies, which have become increasingly important in recent years. These include allogeneic haematopoietic stem cell transplants and CAR-T cell therapies.
In recent years, our clinic has played a key role in the successful clinical development of innovative, personalised molecular and cellular therapies, and we would like to thank many of our patients who have made this progress possible by participating in clinical trials.